Compare StocksCPT vs PFE

Camden Property Trust (CPT) vs Pfizer Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-06-19, CPT is undervalued at $109, with a DCF intrinsic value of $308 and a margin of safety of 65%. PFE is overvalued at $25, with an intrinsic value of $22 and a margin of safety of -12%. Of the two, CPT has the wider margin of safety.

CPT
Camden Property Trust
$108.99
VS
PFE
Pfizer Inc.
$25.21

Rewards

CPT
  • Gross margin of 61.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Trailing P/E of 30.4x is 21% below the historical average of 38.4x — potentially undervalued relative to its own history.
PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • FCF yield of 8.6% is historically attractive — the business generates significant cash relative to its price.
  • Trailing P/E of 19.2x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.

Risks

CPT
  • FCF yield of 6.4% suggests reasonable valuation assuming continued moderate growth.
  • PEG ratio of 9.17 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Net debt/EBITDA of 5.0x indicates heavy leverage — it would take over 4 years of EBITDA to pay off net debt.
PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 13.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Free cash flow has declined at a 29.6% CAGR over the past 4 years — a concerning trend.

Key Valuation Metrics

Learn more →
CPT
PFE
Valuation
$688.08M
Free Cash Flow
$12.38B
6.37%
FCF Yield
8.61%
30.44
Trailing P/E
19.24
68.27
Forward P/E
8.91
Quality & Moat
0.56%
ROIC
10.19%
9.06%
ROE
8.31%
61.62%
Gross Margin
74.80%
9.17
PEG Ratio
13.77
Balance Sheet Safety
1.03
Net Debt / Equity
0.57
N/A
Interest Coverage
N/A
5.04
Net Debt / EBITDA
2.03
3.85%
Dividend Yield
6.61%
CPT: 2Ties: 1PFE: 9
CPTPFE

Historical Fundamentals

Learn more →
CPT

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
CPT
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-395.7M
Δ Market Cap
$-206.6M
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-146.18B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
CPT
64.6% Margin of Safety
Price is 64.6% below estimated fair value
Current Price: $108.99
Fair Value: $307.51
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
12.3% Overvalued
Price is 12.3% above estimated fair value
Current Price: $25.21
Fair Value: $22.46
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
CPT

What growth rate is the market pricing in at $109?

+11.8%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.9%

The market implies +11.8% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.9%, reflecting heavy growth investment.

PFE

What growth rate is the market pricing in at $25?

+5.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +4.5%

The market implies +5.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +4.5%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
CPT
56/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
CPT
-2.77
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
CPT
Insiders 1.5%Institutions 108.6%
No. of Institutional Holders820
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 69.4%Retail & Other 30.5%
No. of Institutional Holders3,744
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
CPT
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
CPT
1
Sells (3M)
10
Sells (12M)
Total value (12M): $9.61M
CAMPO RICHARD J
Officer and Director
$3.37M
@ $112.42 · 2026-06-05
BAKER LAURIE A.
Chief Operating Officer
$235,007
@ $108.40 · 2026-02-18
GALLAGHER MICHAEL P
Officer
$18,325
@ $108.43 · 2026-02-18
BAKER LAURIE A.
Chief Operating Officer
$74,827
@ $109.88 · 2026-01-06
CAMPO RICHARD J
Chief Executive Officer
$4.79M
@ $109.83 · 2026-01-06
JESSETT ALEXANDER J
President
$617,237
@ $109.69 · 2026-01-05
BRUNNER HEATHER J
Director
$230,792
@ $109.69 · 2026-01-05
WESTBROOK KELVIN R
Director
$244,065
@ $109.69 · 2026-01-05
BENITO JAVIER
Director
$11,079
@ $109.69 · 2026-01-05
WEBSTER STEVEN ALAN
Director
$16,814
@ $109.18 · 2026-01-02
WEBSTER STEVEN ALAN
Director
$142,512
@ $118.76 · 2025-05-16
CAMPO RICHARD J
Chief Executive Officer
$2.51M
@ $119.52 · 2025-05-07
GALLAGHER MICHAEL P
Officer
$16,495
@ $122.19 · 2025-03-10
BAKER LAURIE A.
Chief Operating Officer
$273,221
@ $118.38 · 2025-02-19
CAMPO RICHARD J
Chief Executive Officer
$5.36M
@ $119.07 · 2025-02-11
JESSETT ALEXANDER J
President
$1.70M
@ $113.95 · 2025-01-08
BRUNNER HEATHER J
Director
$241,233
@ $113.95 · 2025-01-08
CAMPO RICHARD J
Chief Executive Officer
$953,426
@ $113.95 · 2025-01-08
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
1
Sells (3M)
1
Sells (12M)
Total value (12M): $51,400
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
CPT
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
CPT
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
View CPT Full AnalysisView PFE Full Analysis

Frequently Asked Questions: CPT vs PFE

Is Camden Property Trust or Pfizer Inc. more undervalued in 2026?

Based on our discounted cash flow model, CPT trades at a 64.6% margin of safety (intrinsic value $308 vs. price $109), compared to PFE's -12.3% margin of safety (intrinsic $22 vs. $25).

Which stock has a wider economic moat, Camden Property Trust or Pfizer Inc.?

CPT scores 56/100 (Narrow moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Camden Property Trust in financial distress?

CPT's Altman Z-Score of 1.6 places it in the Distress zone, signaling elevated bankruptcy risk. PFE scores 2.1 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Camden Property Trust or Pfizer Inc.?

Pfizer Inc. (PFE) generates a 8.6% free cash flow yield, compared to Camden Property Trust's 6.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Camden Property Trust or Pfizer Inc.?

PFE earns 10.2% ROIC versus CPT's 0.6%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Camden Property Trust's or Pfizer Inc.'s?

PFE's dividend earns a safety score of 24/100 (Unsafe), compared to CPT's 24/100 (Unsafe). PFE has raised its dividend for 3 consecutive years.